Loading stock data…
SLGL
$75.61+1.57 (+2.12%)
Market ClosedLast close May 1
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Sol-Gel Technologies Ltd. in the Healthcare sector is trading at $75.61. The stock is currently 23% below its 52-week high of $97.97, remaining 58.0% above its 200-day moving average. Technical signals show neutral RSI of 51 and bullish MACD crossover, explaining why SLGL maintains its current momentum and trend strength. The Whystock Score of 75/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Neutral momentum (RSI 51) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$75.61
Potential Upside
5%
Whystock Fair Value$79.39
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus1 analysts
Mean target$110.00+45.5%
Range$110.00 – $110.00
Fundamentals
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The compan...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$238.46M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.27
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-26.86%
Volume
Today's trading volume
10,754
Recent News
US Equity Indexes Fall Amid Uncertainty Over US-Iran Truce Talks
US equity indexes fell on Tuesday as oil prices continued to rise amid uncertainty surrounding truce
Sol-Gel Technologies Ltd. (SLGL) Reports Q4 Loss, Misses Revenue Estimates
SolGel Technologies (SLGL) delivered earnings and revenue surprises of -374.36% and -89.29%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Sol-Gel Technologies (NASDAQ:SLGL) shareholders have earned a 940% return over the last year
Active investing isn't easy, but for those that do it, the aim is to find the best companies to buy, and to profit...
We Think Sol-Gel Technologies (NASDAQ:SLGL) Can Easily Afford To Drive Business Growth
Just because a business does not make any money, does not mean that the stock will go down. For example, Sol-Gel...
Insiders At Sol-Gel Technologies See Good Returns After Buying Stock Worth US$867.1k
Insiders who bought Sol-Gel Technologies Ltd. ( NASDAQ:SLGL ) stock lover the last 12 months are probably not as...